Table 1.

Data analysis from the studies.

Single or Combination Therapy	Drug Used	Clearance	Recurrence
Single therapy	Imiquimod 5%	6 out of 7	No recurrence
Single therapy	Imiquimod 3.75%	1 out of 1	No recurrence
Combination therapy	5% 5-fluorouracil in the morning and 5% imiquimod at night	4 out of 4	No recurrence
Combination therapy	CO2 fractional laser and 5-fluorouracil	16 out of 17	1 recurrence
Combination therapy	Intralesional 5-fluorouracil, and topical trichloroacetic acid	1 out of 1	No recurrence
Single therapy	5% 5-fluorouracil	4 out of 4	No recurrence
Single therapy	0.1% tazarotene	7 out of 15	No recurrence
Total		39 out of 49	1 out of 49